Vilagletistat

N/A

Report date: 2025/12/25 15:59:54
NME

Base Information

Drug NameVilagletistat
Drug Alias NameZED-101ZED-1227TAK-227
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-glutamine gamma-glutamyltransferase inhibitors
TargetsProtein-glutamine gamma-glutamyltransferase
Therapy Area/IndicationsLiver CirrhosisMetabolic Dysfunction-Associated Steatotic Liver DiseaseCeliac Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwedenPoland +[15] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesZedira GmbH
China Registration ClassN/A

Develop Information

Active CompaniesDr Falk Pharma GmbHTakeda Pharmaceutical Co LtdTakeda Development Center Americas Inc
Inactive CompaniesN/A
Active IndicationsLiver CirrhosisMetabolic Dysfunction-Associated Steatotic Liver DiseaseCeliac Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A